Lang Matthew - Insider Non-Derivative Transactions at Lyell Immunopharma, Inc. (LYEL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 9, 2024, Lang Matthew's relationship to Lyell Immunopharma, Inc. (LYEL) is Officer (Chief Business Officer), and currently has 50,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LYEL insiders.
Data Source: SEC.
Lang Matthew - Insider Non-Derivative Transactions at LYEL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 10, 2024 | Acquisition -- (Common Stock) | 50000 | 0 | 50000 |